Molecular and phenotypic characteristics of respiratory syncytial virus isolates recovered from medically vulnerable children An exploratory analysis of a phase 23 randomized doubleblind palivizumabcontrolled trial of Nirsevimab MEDLEY

Simple item page
dc.article.end-page12en
dc.article.start-page1en
dc.citation.doi10.1016/J.VACCINE.2024.126276en
dc.contributor.authorK Tuffyen
dc.contributor.authorB Ahanien
dc.contributor.authorJ Domachowskeen
dc.contributor.authorK Furunoen
dc.contributor.authorShabir Madhien
dc.contributor.authorE et alen
dc.date.accessioned2024-10-19T10:23:38Z
dc.date.available2024-10-19T10:23:38Z
dc.facultyFACULTY OF HEALTH SCIENCESen
dc.identifier.citationWOSen
dc.identifier.issn0264-410Xen
dc.identifier.urihttps://hdl.handle.net/10539/41712
dc.journal.titleMolecular and phenotypic characteristics of respiratory syncytial virus isolates recovered from medically vulnerable children An exploratory analysis of a phase 23 randomized doubleblind palivizumabcontrolled trial of Nirsevimab MEDLEYen
dc.journal.volume42en
dc.titleMolecular and phenotypic characteristics of respiratory syncytial virus isolates recovered from medically vulnerable children An exploratory analysis of a phase 23 randomized doubleblind palivizumabcontrolled trial of Nirsevimab MEDLEYen
dc.typeJournal Articleen
Files
Original bundle
Now showing 1 - 1 of 1
Thumbnail Image
Name:
Journal Article.pdf
Size:
2.95 MB
Format:
Adobe Portable Document Format
Description:
Bitstream uploaded by REST Client
Download
Collections
Academic Wits Research Outputs (All submissions)